Insider · CIK 0001882685
Katherine Allanson
Files at VHC (VirnetX Holding Corp). First filing -, latest -.
In brief
Katherine Allanson files SEC Form 4 as CFO at VHC (VirnetX Holding Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Katherine Allanson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | VHC VirnetX Holding Corp | FTax withholding Common Stock | -100 | $11.95 | $1,195 | 31,205 | Jul 13, 2026 |
| Nov 24, 2025 | VHC VirnetX Holding Corp | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Nov 26, 2025 |
| Jul 7, 2025 | VHC VirnetX Holding Corp | FTax withholding Common Stock | -102 | $12.34 | $1,259 | 31,305 | Jul 11, 2025 |
| Nov 12, 2024 | VHC VirnetX Holding Corp | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 31,407 | Nov 14, 2024 |
Questions about Katherine Allanson
Answered from the filings on this page, as of the latest one.
Is Katherine Allanson buying or selling?
Katherine Allanson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Katherine Allanson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Katherine Allanson has 0.
Where does Katherine Allanson file Form 4?
Katherine Allanson has filed Form 4 at VHC (VirnetX Holding Corp) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.